ResearcherJichi Medical UniversityActive in the last 2 years
Masanobu Taguchi
Matched on ORCID iD 0000-0003-3305-0314; OpenAlex author ID A5075913662. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2025: 2 papers · 2026: 1 paper
Papers 3
- Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic cancer: A propensity score-… Co-author DOI 10.1016/j.suronc.2026.102386↗
- Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with diabetes mellitus. Co-author DOI 10.21037/jgo-2025-457↗
- Pancreatic Ductal Adenocarcinoma with Autoimmune Pancreatitis: A Case Report and Literature Review. Co-author DOI 10.2169/internalmedicine.4361-24↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Naohiro Sata · 3 shared papers, 2025–2026 · strength 0.66
- Paper Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectabl… DOI 10.1016/j.suronc.2026.102386↗
- Paper Pancreatic Ductal Adenocarcinoma with Autoimmune Pancreatitis: A Case Report and Literature Review. DOI 10.2169/internalmedicine.4361-24↗
- Paper Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with … DOI 10.21037/jgo-2025-457↗
- Hironori Yamaguchi · 2 shared papers, 2025–2026 · strength 0.44
- Paper Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectabl… DOI 10.1016/j.suronc.2026.102386↗
- Paper Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with … DOI 10.21037/jgo-2025-457↗
- Yoshiyuki Meguro · 1 shared paper, 2026 · strength 0.23
- Atsushi Kanno · 1 shared paper, 2025 · strength 0.23
- Hironori Yamamoto · 1 shared paper, 2025 · strength 0.23
- Yusuke Sakurai · 1 shared paper, 2025 · strength 0.23
- Noriyoshi Fukushima · 1 shared paper, 2025 · strength 0.23
- Naoki Sano · 1 shared paper, 2025 · strength 0.23
- Rei Takahashi · 1 shared paper, 2025 · strength 0.20
- Joji Kitayama · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.